iShares iBonds Dec 2027 Term Corporate ETF (NYSEARCA:IBDS – Get Free Report) shares saw an uptick in trading volume on Tuesday . 1,207,819 shares traded hands during mid-day trading, an increase of 94% from the previous session’s volume of 623,205 shares.The stock last traded at $24.15 and had previously closed at $24.14.
iShares iBonds Dec 2027 Term Corporate ETF Stock Up 0.0%
The firm has a 50 day moving average price of $24.19 and a 200-day moving average price of $24.24.
Hedge Funds Weigh In On iShares iBonds Dec 2027 Term Corporate ETF
A number of institutional investors have recently bought and sold shares of IBDS. Birchwood Financial Partners Inc. purchased a new position in shares of iShares iBonds Dec 2027 Term Corporate ETF during the fourth quarter worth $50,000. Burkett Financial Services LLC acquired a new stake in shares of iShares iBonds Dec 2027 Term Corporate ETF during the 4th quarter valued at about $61,000. Ascentis Independent Advisors purchased a new stake in shares of iShares iBonds Dec 2027 Term Corporate ETF in the first quarter valued at approximately $85,000. Front Row Advisors LLC increased its holdings in iShares iBonds Dec 2027 Term Corporate ETF by 250.0% in the 3rd quarter. Front Row Advisors LLC now owns 4,200 shares of the company’s stock worth $102,000 after acquiring an additional 3,000 shares in the last quarter. Finally, BOKF NA acquired a new position in shares of iShares iBonds Dec 2027 Term Corporate ETF during the 4th quarter worth about $126,000.
About iShares iBonds Dec 2027 Term Corporate ETF
The iShares iBonds Dec 2027 Term Corporate ETF (IBDS) is an exchange-traded fund that mostly invests in investment grade fixed income. The fund tracks a Bloomberg global index of USD-denominated, investment-grade corporate bonds maturing between December 31, 2026 and December 16, 2027. IBDS was launched on Sep 12, 2017 and is managed by BlackRock.
See Also
- Five stocks we like better than iShares iBonds Dec 2027 Term Corporate ETF
- SK Hynix’s Nasdaq Listing Could Reset the AI Memory Trade
- The AI Chip Sell-Off Looks Scary, But the Real Story May Be Liquidity
- Palantir’s CEO Just Called Out OpenAI and Anthropic
- Abivax: Wall Street Catches Up to the Data
Receive News & Ratings for iShares iBonds Dec 2027 Term Corporate ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares iBonds Dec 2027 Term Corporate ETF and related companies with MarketBeat.com's FREE daily email newsletter.
